PAPGENE, INC.
Baltimore, United States · Founded 2016 · $2.3M raised
- Headquarters
- Baltimore, Maryland
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $2.3M
- Last Round
- $2.3M GrantFeb 2016
- Rounds
- 1
About
PapGene is a molecular diagnostics company founded by Johns Hopkins cancer genomics researchers to commercialize genetic cytology tests for early cancer detection. Using cervical fluid from routine Pap tests, the company developed assays to detect ovarian, endometrial, and bladder cancers. PapGene's technology and team evolved into Thrive Earlier Detection Corp., which was acquired by Exact Sciences for $2.15 billion in 2021.
Summary
PAPGENE, INC. is a Biotech company based in Baltimore, United States, founded in 2016. It has raised $2.3M in total across 1 round, most recently a $2.3M Grant round in Feb 2016. Investors include National Institutes of Health (NIH) - Fast-Track SBIR.
Funding History
Feb 2016
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/papgene-inc"><img src="https://indexed.vc/api/badge/company/papgene-inc" alt="PAPGENE, INC. on Indexed.vc" width="260" height="76" /></a>